MedTrace Logo

Survival of Patients With a Reduction in the Number of Lymph Nodes in Rectal Cancer After Neoadjuvant Chemoradiotherapy

NCT04456283 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2020-07-02

No results posted yet for this study

Summary

Objective: To analyze the survival of patients with a reduction in the number of resected LN in patients submitted to neoadjuvant and total excision of the mesorectum with rectal cancer.

Expected results:

Survival rate between patients Complete Pathologic Response with less than 12 LN and 12 or more LN.

To determine the difference in survival between patients with less than 12 LN in complete versus incomplete response.

Conditions

  • Cancer of Rectum
  • Lymph Node Disease

Interventions

BEHAVIORAL

Survival

5 year survival after Chemoradiation theraphy for Rectal Cancer

Sponsors & Collaborators

  • SERGIO CARLOS NAHAS

    collaborator UNKNOWN

  • CAIO SERGIO NAHAS

    collaborator UNKNOWN

  • Ivan Cecconello

    collaborator UNKNOWN

  • Ulysses Ribeiro Junior

    collaborator UNKNOWN

  • University of Sao Paulo

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-20
Primary Completion
2020-05-15
Completion
2021-07-15

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04456283 on ClinicalTrials.gov